Almirall, S.A. (BME:ALM)

Market Cap	2.01B
Revenue (ttm)	990.63M
Net Income (ttm)	10.15M
Shares Out	213.47M
EPS (ttm)	0.05
PE Ratio	196.50
Forward PE	39.30
Dividend	0.19 (2.04%)
Ex-Dividend Date	May 17, 2024

Volume	20,917
Average Volume	131,842
Open	9.41
Previous Close	9.43
Day's Range	9.41 - 9.54
52-Week Range	8.03 - 10.45
Beta	0.31
RSI	45.01
Earnings Date	May 12, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM